Important: Therapy notes
MHRA advice: Pioglitazone: risk of bladder cancer (December 2014) (www.gov.uk).
Important: Formulation and dosage details
Formulation:
Tablets 15mg, 30mg, 45mg
Dosage:
Refer to pioglitazone prescribing algorithm.
test announcement
For use in type 2 diabetes, refer to guidance.
MHRA advice: Pioglitazone: risk of bladder cancer (December 2014) (www.gov.uk).
Tablets 15mg, 30mg, 45mg
Refer to pioglitazone prescribing algorithm.